Factors influencing the length of hospital stay in patients with acute exacerbations of chronic obstructive pulmonary disease admitted to intensive care units

Quality Management in Health Care

Volumn 23, Issue 2, 2014, Pages 86-93

  Limsuwat, Chok ^a   Mankongpaisarnrung, Charoen ^a   Dumrongmongcolgul, Nat ^a   Nugent, Kenneth ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

acute flare; COPD; length of stay; mortality; risk factors

Indexed keywords

SERUM ALBUMIN;

AGED; APACHE; ARTIFICIAL VENTILATION; COMPLICATION; ENDOTRACHEAL INTUBATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; PLEURAL EFFUSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

AGED; APACHE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTENSIVE CARE UNITS; INTUBATION, INTRATRACHEAL; LENGTH OF STAY; MALE; PLEURAL EFFUSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 84898025842     PISSN: 10638628     EISSN: 15505154     Source Type: Journal    
DOI: 10.1097/QMH.0000000000000024     Document Type: Article

References (31)

1. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153(3):961-966.
2. Murphy SL. Deaths: final data for 1998. Natl Vital Stat Rep. 2000;48(11):1-105.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11): e442.
4. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, Committee GS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256-1276.
5. Strassels SA, Smith DH, Sullivan SD, Mahajan PS. The costs of treating COPD in the United States. Chest. 2001;119(2):344-352.
6. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. http://www.goldcopd.org. Accessed 2012 December 22.
7. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31(1):204-212.
8. Foraker RE, Rose KM, Chang PP, Suchindran CM, McNeill AM, Rosamond WD. Hospital length of stay for incident heart failure: Atherosclerosis Risk in Communities (ARIC) cohort: 1987-2005. J Healthc Qual. 2012;36(1):45-51.
9. Pushparajah S, McClellan R, Henry A, Kuitert LM. Use of a chronic disease management programme in COPD to reduce hospital admissions. Chronic Respir Dis. 2006;3(4):187-193.
10. Utens CM, Goossens LM, Smeenk FW, et al. Effectiveness and cost-effectiveness of early assisted discharge for 10 chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial. BMC Public Health. 2010;10:618.
11. UK Department of Health. Consultation on a Strategy for Services for Chronic Obstructive Pulmonary Disease (COPD) in England. London, England: Department of Health; 2010.
12. Miravitlles M, Murio C, Guerrero T, Gisbert R. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest. 2002;121(5):1449-1455.
13. Saynajakangas O, Kinnunen T, Tuuponen T, Keistinen T. Length of stay and interval to readmission in emergency hospital treatment of COPD. Age Ageing. 2004;33(6):567-570.
14. Roberts CM, Lowe D, Bucknall CE, Ryland I, Kelly Y, Pearson MG. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax. 2002;57(2):137-141.
15. Lacasse Y, Brooks D, Goldstein RS. Trends in the epidemiology of COPD in Canada, 1980 to 1995. COPD and Rehabilitation Committee of the Canadian Thoracic Society. Chest. 1999;116(2):306-313.
16. Jeffrey AA, Warren PM, Flenley DC. Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management. Thorax. 1992;47(1):34-40.
17. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-829.
18. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in 11 chronic obstructive pulmonary disease. Circulation. 2003; 107(11):1514-1519.
19. Nowinski A, Kaminski D, Korzybski D, Stoklosa A, Gorecka D. The impact of comorbidities on the length of hospital treatment in patients with chronic obstructive pulmonary disease. Pneumonol Alergol Pol. 2011;79(6):388-396.
20. Similowski T, Agusti A, MacNee W, Schonhofer B. The potential impact of anaemia of chronic disease in COPD. Eur Respir J. 2006;27(2):390-396.
21. de la Iglesia F, Valino P, Pita S, et al. Factors predicting a hospital stay of over 3 days in patients with acute exacerbation of chronic obstructive pulmonary disease. J Intern Med. 2002;251(6):500-507.
22. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284-249.
23. Mushlin AI, Black ER, Connolly CA. Buonaccorso KM, Eberly SW. The necessary length of hospital stay for chronic pulmonary disease. JAMA. 1991;266(1):80-83.
24. Parappil A, Depczynski B, Collett P, Marks GB. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology. 2010;15(6):918-922.
25. Aziz EF, Javed F, Pratap B, et al. Malnutrition as assessed by nutritional risk index is associated with worse outcome in patients admitted with acute decompensated heart failure: an ACAP-HF data analysis. Heart Int. 2011;6(1):e2.
26. Pardo Cabello AJ, Bermudo Conde S, Manzano Gamero MV. Prevalence and factors associated to malnutrition in patients admitted to a medium-long stay hospital. Nutr Hosp. 2011;26(2):369-375.
27. Almagro P, Cabrera FJ, Diez J, et al. Comorbidities and shortterm prognosis in patients hospitalized for acute exacerbation of COPD. The ESMI study. Chest. 2012;142(5):1126-1133.
28. Global strategy for the diagnosis, management and prevention of COPD. www.goldcopd.org, Accessed January 20, 2014.
29. George PM, Stone RA, Buckingham RJ, Pursey NA, Lowe D, Roberts CM. Changes in NHS organization of care and management of hospital admissions with COPD exacerbations between the national COPD audits of 2003 and 2008. QJM 2011;104:859-866.
30. Roberts CM, Lopez-Campos JL, Pozo-Rodriguez F, Hartl S. European hospital adherence to GOLD recommendations form chronic obstructive pulmonary disease (COPD) exacerbation admissions. Thorax. 2013;68:1169-1171.
31. Nishimura K, Yasui M, Nishimura T, Oga T. Clinical pathways fro acute exacerbations of chronic obstructive pulmonary disease: method development and five years experience. International J COPD. 2011;6:365-372.